Study to Assess OCT: RNFL and GCL in MS Patients

Completed

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to collect preliminary data on retinal nerve fiber layer and ganglion cell layer damage in multiple sclerosis (MS) patients, using optical coherence tomography (OCT). For this study the Zeiss Cirrus OCT Imaging System will be used. The same system will be used consistently for the duration of the study.

Key facts

Study ID

NCT03313843

Run by

Tampa Bay Uveitis Center, LLC

People needed

73

Starts

2018-02-09

Expected to finish

2021-04-30

Last updated by the study team

2021-06-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or older
• Pregnant women will be excluded by self declaration
• Male or female
• A diagnosis of MS, that meets the 2010 Revised McDonald Diagnostic Criteria
• A visual acuity of 20/400 or better in at least one eye

You may not qualify if…

• Any ocular disease than prevents assessment of the optic nerve and macula by OCT
• Advance glaucoma with optic nerve damage
• Any optic neuropathy not diagnosed as ON associated with MS
• A diagnosis of Macular Degeneration
• Any previous ocular trauma
• Any medical history of a cerebrovascular accident
• Any planned ocular or systemic elective surgery during study duration
• Any contraindication to a comprehensive dilated ophthalmic examination
• Inability to give informed consent

Where it is running

• Tampa Bay Uveitis Center — New Port Richey, Florida, United States
• Tampa Bay Uveitis Center — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.